A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70211 Kuopio, Finland.
Stem Cell and Metabolism Research Program, Research Programs Unit, University of Helsinki, 00290 Helsinki, Finland.
Cells. 2022 Aug 19;11(16):2593. doi: 10.3390/cells11162593.
The m.3243A>G mutation in mitochondrial is one of the most common pathogenic mitochondrial DNA mutations in humans. The clinical manifestations are highly heterogenous and the causes for the drastic clinical variability are unknown. Approximately one third of patients suffer from cardiac disease, which often increases mortality. Why only some patients develop cardiomyopathy is unknown. Here, we studied the molecular effects of a high m.3243A>G mutation load on cardiomyocyte functionality, using cells derived from induced pluripotent stem cells (iPSC-CM) of two different m.3243A>G patients, only one of them suffering from severe cardiomyopathy. While high mutation load impaired mitochondrial respiration in both patients' iPSC-CMs, the downstream consequences varied. mtDNA mutant cells from a patient with no clinical heart disease showed increased glucose metabolism and retained cellular ATP levels, whereas cells from the cardiac disease patient showed reduced ATP levels. In this patient, the mutations also affected intracellular calcium signaling, while this was not true in the other patient's cells. Our results reflect the clinical variability in mitochondrial disease patients and show that iPSC-CMs retain tissue specific features seen in patients.
线粒体 中的 m.3243A>G 突变是人类最常见的致病性线粒体 DNA 突变之一。其临床表现高度异质性,导致临床表现明显差异的原因尚不清楚。大约三分之一的患者患有心脏病,这通常会增加死亡率。为什么只有一些患者会发展为心肌病尚不清楚。在这里,我们使用来自两名不同 m.3243A>G 患者的诱导多能干细胞(iPSC-CM)衍生的细胞,研究了高 m.3243A>G 突变负荷对心肌细胞功能的分子影响,其中只有一名患者患有严重的心肌病。虽然高突变负荷会损害两名患者的 iPSC-CM 中的线粒体呼吸,但下游后果却有所不同。来自无临床心脏病患者的 mtDNA 突变细胞表现出增加的葡萄糖代谢和保留的细胞内 ATP 水平,而来自心脏病患者的细胞则表现出降低的 ATP 水平。在这名患者中,突变还影响细胞内钙信号,而在另一名患者的细胞中则并非如此。我们的结果反映了线粒体疾病患者的临床变异性,并表明 iPSC-CM 保留了患者中存在的组织特异性特征。